您要查找的是不是：
- medium molecular dextran 中分子右旋糖酐
- Methods Clinical study was made in 13 cases with ARF by low Molecular Dextran. 方法:回顾性分析13例低分子右旋糖酐致急性肾功能衰竭的临床资料。
- Abstract：Objective discuss easy effect factor of low Molecular Dextran possible reason and attention things of using in clinic. 摘要]目的：探讨低分子右旋糖酐治疗缺血性脑血管病致急性肾功能衰竭的易感因素、可能原因及临床使用注意事项。
- Conclusion Low Molecular Dextran should be forbid or used prudence in AICVD patient who amalgamate high years old、 high blood press、 diabetes、 high blood grease. 结论:在治疗有上述合并症的缺血性脑血管病患者时,应禁用或慎用低分子右旋糖酐。
- The patients were randomly divided into two groups:one treated with pentoxifylline (PTX) and the other treated with low molecular dextran and acetylsalicylic acid(LMD+ASA). 并随机将患者分为己酮可可碱（PTX）组和低分子右旋糖酐（LMD）＋乙酰水杨酸（ASA）组对照干预治疗。
- Methods: 45 cases of patients with DVT were intravenously injected with Danshen injection and low molecular dextran,took modified Tao Hong Si Wu decoction. 方法45例下肢DVT患者,采用静点丹参注射液、低分子右旋糖酐等,口服中药桃红四物汤加减及配合按摩、穿逐级加压弹力袜进行肌肉、关节的功能锻炼。
- Objective To explore the relationship between functional constipation and medium molecular substance. 目的探讨功能性便秘与血浆中分子物质的关系。
- Conclusion Low Molecular Dextran should be forbid or used prudence in AICVD patient who amalgamate high years old 、high blood press、 diabetes、high blood grease. 结论：在治疗有上述合并症的缺血性脑血管病患者时，应禁用或慎用低分子右旋糖酐。[关键词]低分子右旋糖酐；缺血性脑血管病(AICVD)；
- Conclusion Plasma medium molecular substance content increases in functional constipation patients. 结论功能性便秘患者血浆内中分子物质含量增加。
- Methods:64cases in treating group were treated with defibrase to thrombolysis,58cases in control group were treated with5%low molecular dextran plus troxerutin. 方法:治疗组64例采用降纤酶治疗脑梗塞,对照组58例采用5%25低分子右旋糖酐加维脑路通注射液静脉滴注治疗脑梗塞,进行对比观察。
- AIM: Rat models of disseminated intravascular coagulation (DIC) were established with high molecular dextran to explore its effects on hemodynamic changes in rats and acknowledge whether the mechanism is related with the injection speed. 目的:应用高分子右旋糖酐复制大鼠弥散性血管内凝血模型,观察高分子右旋糖酐对大鼠血液动力学的影响,并了解其作用是否与注射速度相关。
- There is obvious hemodynamic abnormity in rats with DIC induced by high molecular dextran, and the model can be widely applied with stable effect, which is not related with the injection speed. 高分子右旋糖酐所致大鼠实验性弥散性血管内凝血具有明显的血液动力学异常,该模型应用范围广,效果稳定,其效果与注射速度无关。
- CHEN QN, LIU YJ.The effective observation of molecular dextran and small dosage heparin to treat 115 cases nephritic syndrome low protein edema[J].China Journal of Modern Medicine,2003, 13(2): 84-86. [13]陈秋牛;刘育进.;低分子右旋糖酐加小剂量肝素治疗肾病综合征低蛋白水肿115例疗效观察[J]
- Methods:The patients with portal hypertension were early treated with salivia miltiorrhia,low molecular dextran and oral administration of dipyridamole,however,no hemostatic drugs were used. 方法:门脉高压症行门奇断流术后不用止血剂,并早期静滴丹参注射液、低分子右旋糖酐、口服潘生丁,观察血小板计数,凝血酶原时间(PT)变化和门静脉系血栓形成的长度变化。
- Obictive:To evaluate the influences of preoperative acute hypervolemic hemodilution (AHHD) with 6% medium molecular Hydroxyethl startch(HES 200/0.5) on the activity of coagulation. 目的 :观察 6%25羟乙基淀粉 (贺斯 ;HES 2 0 0 / 0 .;5 )为容量扩充剂行术前急性高容血液稀释 (AHHD)对凝血功能的影响。
- A titanium-based Ziegler-Natta catalyst was developed with high activity, stable kinetic behaviors and ready-responding to hydrogen adjustment. PE obtained over the catalyst was of medium molecular weight distribution. 摘要合成了一种钛系齐格勒－纳塔烯烃聚合催化剂，该催化剂具有较高的乙烯聚合活性，其乙烯聚合动力学平稳，氢调敏感，所得到的乙烯聚合物具有中等分子量分布。
- medium molecular weight hydroxyethyl starch 中分子羟乙基淀粉（贺斯）
- English is not the usual medium of instruction in our school. 英语不是我校通常使用的教学语言。
- An ASCII control character, end of medium. 一种ASCII码控制字符，媒体结束符。
- This cloth is of medium quality. 这种布质量平平。
- 今日热词
-
- 深远海浮式风电平台 - deep-sea floating wind power platform
-
- 京雄高速公路 - Beijing-Xiongan expressway
-
- 农业及相关产业增加值 - the added value of agriculture and related industries
